Colgate-Palmolive (CL) HR chief exercises options, sells 15,851 shares

Filing Impact

(Very High)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

Colgate-Palmolive Chief Human Resources Officer Sally Massey reported an option exercise and related share sale. On February 5, 2026, she exercised stock options for 15,851 shares of common stock at $76.41 per share, awarded under the company’s incentive compensation plan.

That same day, she sold 15,851 shares of common stock at a weighted average price of $95.0279, with part of the proceeds used to pay the option exercise price and related tax withholding. After these transactions, she directly owned 13,751 shares of Colgate-Palmolive common stock and held an additional 8,111 shares indirectly through the issuer’s 401(k) plan trustee.

Insider Trade Summary

Net Seller: 15,851 shares ($1,506,287)

Net Sell 4 txns

Insider Massey Sally

Role Chief Human Resources Officer

Sold 15,851 shs ($1.51M)

Type	Security	Shares	Price	Value
Exercise	Stock Option (Right to Buy)	15,851	$0.00	--
Exercise	Common Stock	15,851	$76.41	$1.21M
Sale	Common Stock	15,851	$95.0279	$1.51M
holding	Common Stock	--	--	--

Holdings After Transaction: Stock Option (Right to Buy) — 0 shares (Direct); Common Stock — 29,602 shares (Direct); Common Stock — 8,111 shares (Indirect, By Issuer's 401(k) Plan Trustee)

Footnotes (1)

Exercise of stock options awarded under the issuer's incentive compensation plan. Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's incentive compensation plan and the related tax withholding. Weighted average price, as these shares were sold in multiple transactions at prices ranging from $95.02 to $95.045 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote. Option became exercisable in one-third increments beginning on the first anniversary of the September 10, 2020 grant date.

Form 4 Insider Transactions: What Each Field Means →

02/09/2026 - 04:16 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Massey Sally

(Last)

(First)

(Middle)

C/O COLGATE-PALMOLIVE COMPANY

300 PARK AVENUE

(Street)

NEW YORK

10022

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
COLGATE PALMOLIVE CO [ CL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Human Resources Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/05/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	02/05/2026		M⁽¹⁾		15,851	A	$76.41	29,602	D
Common Stock	02/05/2026		S⁽²⁾		15,851	D	$95.0279⁽³⁾	13,751	D
Common Stock								8,111	I	By Issuer's 401(k) Plan Trustee

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option (Right to Buy)	$76.41	02/05/2026		M⁽¹⁾			15,851	⁽⁴⁾	09/10/2028	Common Stock	15,851	$0.0000	0.0000	D

Explanation of Responses:

1. Exercise of stock options awarded under the issuer's incentive compensation plan.

2. Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's incentive compensation plan and the related tax withholding.

3. Weighted average price, as these shares were sold in multiple transactions at prices ranging from $95.02 to $95.045 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote.

4. Option became exercisable in one-third increments beginning on the first anniversary of the September 10, 2020 grant date.

	/s/ Kristine Hutchinson, Attorney-in-Fact	02/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Colgate-Palmolive (CL) disclose for Sally Massey?

Colgate-Palmolive reported that Chief Human Resources Officer Sally Massey exercised options and sold shares. On February 5, 2026, she exercised 15,851 stock options and sold 15,851 common shares in related transactions under the company’s incentive compensation plan.

How many Colgate-Palmolive (CL) stock options did Sally Massey exercise?

Sally Massey exercised 15,851 Colgate-Palmolive stock options on February 5, 2026. These options, with a $76.41 exercise price, were granted under the issuer’s incentive compensation plan and had become exercisable in one-third increments starting after the September 10, 2020 grant.

At what price were Sally Massey’s Colgate-Palmolive (CL) options exercised and shares sold?

The stock options were exercised at $76.41 per share and the resulting shares sold at a weighted average $95.0279. The sale price reflects multiple trades between $95.02 and $95.045, as disclosed in the transaction footnote.

How many Colgate-Palmolive (CL) shares does Sally Massey hold after the reported transactions?

After the transactions, Sally Massey directly owned 13,751 Colgate-Palmolive common shares. She also had an additional 8,111 shares held indirectly through the issuer’s 401(k) plan trustee, according to the Form 4 filing.

Why were some Colgate-Palmolive (CL) shares sold in connection with Sally Massey’s option exercise?

The filing states that a portion of sale proceeds was delivered to Colgate-Palmolive. These proceeds were used to pay the exercise price for the stock options under the incentive compensation plan and to cover related tax withholding obligations.

What role does Sally Massey hold at Colgate-Palmolive (CL)?

Sally Massey is identified as Colgate-Palmolive’s Chief Human Resources Officer. The Form 4 confirms she is an officer of the company, not a director or 10% owner, and reports her equity transactions in that capacity.